Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Sep 18, 2023
Amorphous Nasal Powder Advanced Performance: "In Vitro/Ex Vivo" Studies and Correlation with "In Vivo" Pharmacokinetics
Read more
Scientific Article
Scientific Article
/ Aug 31, 2023
Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery
Read more
Scientific Article